Xiaoning Lin1, Rong Huang2, Pengfei Zhang3, Jin Sun1, Guijiang Dong1, Yanlin Huang1, Xinhua Tian1. 1. Department of Neurosurgery, Zhongshan Hospital Xiamen University, Xiamen, China. 2. Department of Child Health, Women and Children's Hospital, Xiamen University, Xiamen, China. 3. Institute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Abstract
BACKGROUND: Low-grade gangliogliomas (GGs) are rare tumors of the central nervous system in adults. This study aims to define their characteristics, prognostic factors, and the impact of different treatment patterns on survival. METHODS: The Surveillance, Epidemiology, and End Results (SEER) database was used to investigate the potential clinicopathological factors of low-grade GGs in adult patients (age ≥18 years). Kaplan-Meier method and Cox regression model were utilized to evaluate the associations between variables and overall survival (OS). RESULTS: A total of 703 adult patients diagnosed with low-grade GGs were identified between 2004 and 2016, with a median follow-up period of 60.0 months. The median age at diagnosis was 32.0 years, with 50.1% of patients being male, 84.2% white people, and 40.2% of married status. The predominant tumor site was located in temporal lobe (38.8%). The median OS time for the whole cohort was not reached. The 5- and 10-year OS rates for patients underwent gross total resection (GTR) were 92.5% and 87.2%, respectively. Univariate and multivariate analysis showed age, gender, tumor site, and treatment pattern were significant factors for OS. The employment of adjuvant radiotherapy (RT) and/or chemotherapy would significantly shorten OS time. CONCLUSIONS: This is the largest retrospective study of adult low-grade GGs up to date. Younger age, female gender, temporal lobe location, and GTR indicated better survival. Adjuvant RT and/or chemotherapy should not be considered after whatever surgery in adult patients with low-grade GGs, unless the malignant transformation has been confirmed.
BACKGROUND: Low-grade gangliogliomas (GGs) are rare tumors of the central nervous system in adults. This study aims to define their characteristics, prognostic factors, and the impact of different treatment patterns on survival. METHODS: The Surveillance, Epidemiology, and End Results (SEER) database was used to investigate the potential clinicopathological factors of low-grade GGs in adult patients (age ≥18 years). Kaplan-Meier method and Cox regression model were utilized to evaluate the associations between variables and overall survival (OS). RESULTS: A total of 703 adult patients diagnosed with low-grade GGs were identified between 2004 and 2016, with a median follow-up period of 60.0 months. The median age at diagnosis was 32.0 years, with 50.1% of patients being male, 84.2% white people, and 40.2% of married status. The predominant tumor site was located in temporal lobe (38.8%). The median OS time for the whole cohort was not reached. The 5- and 10-year OS rates for patients underwent gross total resection (GTR) were 92.5% and 87.2%, respectively. Univariate and multivariate analysis showed age, gender, tumor site, and treatment pattern were significant factors for OS. The employment of adjuvant radiotherapy (RT) and/or chemotherapy would significantly shorten OS time. CONCLUSIONS: This is the largest retrospective study of adult low-grade GGs up to date. Younger age, female gender, temporal lobe location, and GTR indicated better survival. Adjuvant RT and/or chemotherapy should not be considered after whatever surgery in adult patients with low-grade GGs, unless the malignant transformation has been confirmed.
Authors: Roy W R Dudley; Michelle R Torok; Danielle R Gallegos; Jean M Mulcahy-Levy; Lindsey M Hoffman; Arthur K Liu; Michael H Handler; Todd C Hankinson Journal: Neurosurgery Date: 2015-03 Impact factor: 4.654
Authors: Dirk Rades; Lena Zwick; Jan Leppert; Matteo M Bonsanto; Volker Tronnier; Juergen Dunst; Steven E Schild Journal: Cancer Date: 2010-01-15 Impact factor: 6.860
Authors: David N Louis; Arie Perry; Peter Burger; David W Ellison; Guido Reifenberger; Andreas von Deimling; Kenneth Aldape; Daniel Brat; V Peter Collins; Charles Eberhart; Dominique Figarella-Branger; Gregory N Fuller; Felice Giangaspero; Caterina Giannini; Cynthia Hawkins; Paul Kleihues; Andrey Korshunov; Johan M Kros; M Beatriz Lopes; Ho-Keung Ng; Hiroko Ohgaki; Werner Paulus; Torsten Pietsch; Marc Rosenblum; Elisabeth Rushing; Figen Soylemezoglu; Otmar Wiestler; Pieter Wesseling Journal: Brain Pathol Date: 2014-09-10 Impact factor: 6.508
Authors: David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues Journal: Acta Neuropathol Date: 2007-07-06 Impact factor: 17.088
Authors: Antonia Carmen Lisievici; Diana Pasov; Tiberiu-Augustin Georgescu; Mihai Gheorghe Lisievici; Maria Sajin Journal: J Med Life Date: 2021 Mar-Apr
Authors: Osama A Al-Dalahmah; Linda Wang; Susan J Hsiao; Chun-Chieh Lin; Mahesh M Mansukhani; Peter Canoll; Jeffrey N Bruce; George Zanazzi Journal: Surg Neurol Int Date: 2022-06-10